ABSTRACT
INTRODUCTION: Electronic health record (EHR) usability, defined as the extent to which the system can be used to complete tasks, can influence patient outcomes. The aim of this study is to assess the relationship between EHR usability and postsurgical outcomes of older adults with dementia including 30-day readmission, 30-day mortality, and length of stay (LOS). METHODS: A cross-sectional analysis of linked American Hospital Association, Medicare claims data, and nurse survey data was conducted using logistic regression and negative binominal models. RESULTS: The dementia population who received care in hospitals with better EHR usability were less likely to die within 30 days of their admission following surgery compared to hospitals with poorer EHR usability (OR: 0.79, 95% CI: 0.68-0.91, p = 0.001). EHR usability was not associated with readmission or LOS. DISCUSSION: Better nurse reported EHR usability has the potential to reduce mortality rates among older adults with dementia in hospitals.
Subject(s)
Dementia , Electronic Health Records , Humans , Aged , United States , Cross-Sectional Studies , Medicare , Patient Readmission , Dementia/surgeryABSTRACT
BACKGROUND: The purpose of the current study was to investigate the incidence of postoperative medical complications and 3-month mortality in patients ≥ 70 years old with hip fracture following hip arthroplasty (HA) and independent risk factors associated with postoperative medical complications and 3-month mortality during the Coronavirus Disease 2019 (COVID-19) pandemic. METHODS: A multicenter retrospective study was conducted, patients ≥ 70 years old with HA for hip fracture under general anesthesia were included during COVID-19 and before COVID-19 pandemic. The outcome was defined as postoperative medical complications and 3-month mortality. The baseline characteristics and risk factors were collected, multivariable logistic regression was used to identify independent risk factors for postoperative medical complications and 3-month mortality. RESULTS: A total of 1096 patients were included during COVID-19 pandemic and 1149 were included before COVID-19 pandemic in the study. Patients ≥ 70 years with hip fracture for HA had longer fracture to operation duration (7.10 ± 3.52 vs. 5.31 ± 1.29, P < 0.001), and the incidence of postoperative medical complications (21.90% vs. 12.53%, P < 0.001) and 3-month mortality (5.20% vs. 3.22%, P = 0.025) was higher during COVID-2019 pandemic. Multivariate logistic regression analysis showed that dementia (OR 2.73; 95% CI 1.37-5.44; P = 0.004), chronic obstructive pulmonary disease (COPD) (OR 3.00; 95% CI 1.92-4.71; P < 0.001), longer fracture to operation duration (OR 1.24; 95% CI 1.19-1.30; P < 0.001) were associated with increased risk for postoperative medical complications. COPD (OR 2.10; 95% CI 1.05-4.17; P = 0.035), dementia (OR 3.00; 95% CI 1.11-7.94; P = 0.031), postoperative medical complications (OR 4.99; 95% CI 2.68-9.28; P < 0.001), longer fracture to operation duration (OR 1.11; 95% CI 1.04-1.19; P = 0.002) were associated with increased risk for 3-month mortality. CONCLUSIONS: In conclusion, we found that postoperative medical morbidity and 3-month mortality in patients with hip fracture underwent HA were 21.90% and 5.20%, respectively, during the COVID-19. COPD, dementia and longer fracture to operation duration were associated with negative outcome in patients with hip fracture underwent HA during the COVID-19.
Subject(s)
Arthroplasty, Replacement, Hip , COVID-19 , Dementia , Hip Fractures , Pulmonary Disease, Chronic Obstructive , Humans , Aged , Pandemics , Retrospective Studies , COVID-19/epidemiology , Arthroplasty, Replacement, Hip/adverse effects , Hip Fractures/epidemiology , Hip Fractures/surgery , Risk Factors , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/epidemiology , Pulmonary Disease, Chronic Obstructive/surgery , Incidence , Dementia/surgery , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/surgeryABSTRACT
BACKGROUND: Optimal periprocedural oral anticoagulant (OAC) therapy before catheter ablation (CA) for atrial fibrillation (AF) and the safety profile of OAC discontinuation during the remote period (from 31 days and up to 1 year after CA) have not been well defined.MethodsâandâResults: The RYOUMA registry is a prospective multicenter observational study of Japanese patients who underwent CA for AF in 2017-2018. Of the 3,072 patients, 82.3% received minimally interrupted direct-acting OACs (DOACs) and 10.2% received uninterrupted DOACs. Both uninterrupted and minimally interrupted DOACs were associated with an extremely low thromboembolic event rate. Female, long-standing persistent AF, low creatinine clearance, hepatic disorder, and high intraprocedural heparin dose were independent factors associated with periprocedural major bleeding. At 1 year after CA, DOAC was continued in 55.9% of patients and warfarin in 56.4%. The incidence of thromboembolic and major bleeding events for 1 year was 0.3% and 1.2%, respectively. Age ≥73 years, dementia, and AF recurrence were independently associated with major bleeding events. Univariate analyses revealed that warfarin continuation and off-label overdose of DOACs were risk factors for major bleeding after CA. CONCLUSIONS: High intraprocedural dose of heparin was associated with periprocedural major bleeding events. At 1 year after CA, over half of the patients had continued OAC therapy. Thromboembolic events were extremely low; however, major bleeding occurred in 1.2%. Age ≥73 years, dementia, and AF recurrence were independently associated with major bleeding after CA.
Subject(s)
Atrial Fibrillation , Catheter Ablation , Dementia , Thromboembolism , Humans , Female , Aged , Atrial Fibrillation/drug therapy , Atrial Fibrillation/surgery , Warfarin/therapeutic use , Japan/epidemiology , Prospective Studies , Treatment Outcome , Anticoagulants/therapeutic use , Hemorrhage/chemically induced , Hemorrhage/epidemiology , Thromboembolism/epidemiology , Thromboembolism/etiology , Thromboembolism/prevention & control , Heparin/adverse effects , Catheter Ablation/adverse effects , Catheter Ablation/methods , Dementia/surgery , Administration, OralABSTRACT
BACKGROUND: Hemiarthroplasty is a common treatment for displaced femoral neck fractures, but limited Canadian data are available about hemiarthroplasty failure. We evaluated the frequency and predictors of hemiarthroplasty failure in Manitoba. METHODS: In this retrospective multicentre province-wide study, billing and joint registry databases showed 4693 patients who had hemiarthroplasty for treatment of femoral neck fracture in Manitoba over an 11-year period (2005-2015), including 155 hips with subsequent reoperations (open or closed) for treatment of hemiarthroplasty failure. Hospital records were reviewed to identify modes of hemiarthroplasty failure, comorbidities and reoperations. Data were analyzed using χ2 test and Poisson and γ regression models. RESULTS: During our study period, 155 hips (154 patients [3%]) underwent 230 reoperations. Of these, 131 hips (85%) initially had an uncemented unipolar modular implant. Indications for first-time reoperation included periprosthetic femur fracture (49 hips [32%]), dislocation (45 hips [29%]), acetabular wear (28 hips [18%]) and infection (26 hips [17%]). There were 46 hips (30%) that had 2 or more reoperations. Reoperation for dislocation was associated with presence of dementia; acetabular wear was associated with absence of dementia. Time from hemiarthroplasty to reoperation was associated inversely with age at hemiarthroplasty, dislocation and dementia and was directly associated with acetabular wear. The risk of having 2 or more reoperations was associated independently with dislocation, infection, and alcohol abuse. CONCLUSION: Hemiarthroplasty for femoral neck fracture in Manitoba had a low frequency of failure. Risk factors for multiple reoperations included dislocation, infection and alcohol abuse.
Subject(s)
Alcoholism , Arthroplasty, Replacement, Hip , Dementia , Femoral Neck Fractures , Hemiarthroplasty , Hip Prosthesis , Periprosthetic Fractures , Alcoholism/complications , Alcoholism/surgery , Arthroplasty, Replacement, Hip/adverse effects , Canada , Dementia/complications , Dementia/surgery , Femoral Neck Fractures/complications , Femoral Neck Fractures/surgery , Hemiarthroplasty/adverse effects , Hip Prosthesis/adverse effects , Humans , Periprosthetic Fractures/complications , Periprosthetic Fractures/surgery , Reoperation/adverse effects , Treatment OutcomeABSTRACT
PURPOSE: Atrial fibrillation is associated with an increased risk of cognitive impairment. It is unclear whether the restoration of sinus rhythm with catheter ablation may modify this risk. We conducted a systematic review of studies comparing cognitive outcomes following catheter ablation with medical therapy (rate and/or rhythm control) in atrial fibrillation. METHODS: Searches were performed on the following databases from their inception to 17 October 2021: PubMed, OVID Medline, Embase and Cochrane Library. The inclusion criteria comprised studies comparing catheter ablation against medical therapy (rate and/or rhythm control in conjunction with anticoagulation where appropriate) which included cognitive assessment and/or a diagnosis of dementia as an outcome. RESULTS: A total of 599 records were screened. Ten studies including 15,886 patients treated with catheter ablation and 42,684 patients treated with medical therapy were included. Studies which compared the impact of catheter ablation versus medical therapy on quantitative assessments of cognitive function yielded conflicting results. In studies, examining new onset dementia during follow-up, catheter ablation was associated with a lower risk of subsequent dementia diagnosis compared to medical therapy (hazard ratio: 0.60 (95% confidence interval 0.42-0.88, p < 0.05)). CONCLUSION: The accumulating evidence linking atrial fibrillation with cognitive impairment warrants the design of atrial fibrillation treatment strategies aimed at minimising cognitive decline. However, the impact of catheter ablation and atrial fibrillation medical therapy on cognitive decline is currently uncertain. Future studies investigating atrial fibrillation treatment strategies should include cognitive outcomes as important clinical endpoints.
Subject(s)
Atrial Fibrillation , Catheter Ablation , Dementia , Anticoagulants/therapeutic use , Catheter Ablation/methods , Cognition , Dementia/complications , Dementia/surgery , Humans , Treatment OutcomeABSTRACT
Information regarding fracture in patients with transcatheter aortic valve replacement (TAVR) is limited. We investigated the prevalence and impact of fracture in patients with severe aortic stenosis who had undergone TAVR. Of 913 consecutive patients with symptomatic, severe aortic stenosis who underwent TAVR at the Sakakibara Heart Institute between October 2013 and April 2020, 633 women were enrolled. The primary endpoint was all-cause mortality following TAVR. Patients with a history of fracture displayed smaller body mass indices, increased frailty, a higher prevalence of osteoporosis, and stroke history. Notably, 61.7% of patients with a history of fracture reported to have not taken any osteoporosis medications. Estimated all-cause mortality survival rates post-TAVR were significantly lower in patients with fractures than those without fractures. In the multivariate analysis, history of fracture was independently associated with all-cause mortality following TAVR. Furthermore, fracture prevalence was significantly greater in those who had a higher clinical frailty scale score were slower in the 5-m walk test, had more severe dementia as per the revised Hasegawa dementia scale, and performed poorly in the hand grip strength test. History of fracture was an independent predictor for all-cause mortality in patients undergoing TAVR. In addition, our study demonstrated that osteoporotic fracture may be under-treated in this population. History of fracture may be one of the phenotypes of frailty given its significant relationship with frailty markers in this population.
Subject(s)
Aortic Valve Stenosis , Dementia , Frailty , Osteoporosis , Transcatheter Aortic Valve Replacement , Aortic Valve/surgery , Aortic Valve Stenosis/complications , Aortic Valve Stenosis/epidemiology , Aortic Valve Stenosis/surgery , Dementia/complications , Dementia/surgery , Female , Frailty/complications , Frailty/diagnosis , Frailty/epidemiology , Hand Strength , Humans , Osteoporosis/complications , Osteoporosis/epidemiology , Postmenopause , Prevalence , Risk Factors , Severity of Illness Index , Transcatheter Aortic Valve Replacement/adverse effects , Treatment OutcomeABSTRACT
BACKGROUND: Cataract surgery substantially improves patient quality of life. Despite the rising prevalence of dementia in the US, little is known about use of cataract surgery among this group. OBJECTIVE: To evaluate the relationship between dementia status and cataract surgery. METHODS: Using administrative insurance claims for a representative sample of 1,125,387 US Medicare beneficiaries who received eye care between 2006 and 2015, we compared cataract surgery rates between patients with and without dementia via multivariable regression models to adjust for patient characteristics. Main outcome measures were annual rates of cataract surgery and hazard ratio and 95% confidence interval (CI) for receiving cataract surgery. RESULTS: Cataract surgery was performed in 457,128 patients, 23,331 with a prior diagnosis of dementia. 16.7% of dementia patients underwent cataract surgery, compared to 43.8% of patients without dementia. 59 cataract surgeries were performed per 1000 dementia patients annually, versus 105 surgeries per 1000 nondementia patients. After adjusting for patient characteristics, dementia patients were approximately half as likely to receive cataract surgery compared to nondementia patients (adjusted HRâ=â0.53, 95% CI 0.53-0.54). Among the subset of patients who received a first cataract surgery, those with dementia were also less likely to receive second-eye cataract surgery (adjusted HRâ=â0.87, 95% CI 0.86-0.88). CONCLUSION: US Medicare patients with dementia are less likely to undergo cataract surgery than those without dementia. This finding has implications for quality of care and dementia progression. More information is necessary to understand why rates of cataract surgery are lower for these patients, and to identify conditions where benefits of surgery may outweigh risks.
Subject(s)
Cataract Extraction/trends , Cataract/epidemiology , Dementia/epidemiology , Dementia/surgery , Medicare/trends , Aged , Aged, 80 and over , Cataract/psychology , Dementia/psychology , Female , Follow-Up Studies , Humans , Incidence , Lens, Crystalline/pathology , Lens, Crystalline/surgery , Male , United States/epidemiologyABSTRACT
OBJECTIVE: This study was designed to verify the association between dementia and mortality in the elderly undergoing hip fracture surgery, and assessed the mortality of patients with dementia after hip fracture surgery. MATERIAL AND METHODS: PubMed, Embase, and Web of Science were searched until April, 2018 without language restrictions. Two reviewers selected related studies, assessed study quality, and extracted data independently. Risk ratios (RRs) with 95% confidence intervals (CI) were derived using random-effects model throughout all analyses. The endpoints included 30-day, 6-month, 1-year, and more than 1-year mortality. This meta-analysis was performed following PRISMA statement and carried out by using stata14.0 software. RESULTS: Dementia significantly increased postoperative mortality of patients suffered from hip fracture in 30-day [RR = 1.57, 95% CI (1.29, 1.90), P<0.00], 6-month [RR = 1.97, 95% CI (1.47, 2.63), P<0.00], 1-year [RR = 1.77, 95% CI (1.54, 2.04), P<0.00], and more than 1-year follow up [RR = 1.60, 95% CI (1.30, 1.96), P<0.00] respectively. The mortality of dementia patients after hip fracture surgery in 30-day [ES = 12%, 95% CI (8%, 15%)], 6-month [ES = 32%, 95% CI (17%, 48%)], 1-year [ES = 39%, 95% CI (35%, 43%)], and more than 1-year follow up [ES = 45%, 95% CI (32%, 58%)]. CONCLUSIONS: Our meta-analysis demonstrated that the mortality of patients with dementia suffered from hip fracture surgery is 12%, 32%, 39%, and 45%, and dementia increased 1.57, 1.97, 1.77, and 1.60-fold mortality in patients undergoing hip fracture surgery in 30-day, 6-month, 1-year, and more than 1-year follow up respectively.
Subject(s)
Dementia/mortality , Dementia/surgery , Hip Fractures/mortality , Hip Fractures/surgery , Postoperative Complications/mortality , Aged , Aged, 80 and over , Dementia/diagnosis , Humans , Mortality/trends , Postoperative Complications/diagnosis , Prospective Studies , Retrospective Studies , Risk FactorsABSTRACT
BACKGROUND: The strategy for cardiovascular surgery in dementia patients is controversial, so we aimed to investigate whether preoperative dementia and its severity might affect the outcomes of cardiovascular surgery by evaluating with the Mini-Mental State Examination (MMSE). MethodsâandâResults: The study group comprised 490 patients undergoing cardiovascular surgery. Their preoperative cognitive status was evaluated using the MMSE, and analysis was performed to compare the patients with MMSE score <24 (dementia group, n=51) or MMSE score 24-30 (non-dementia group, n=439). Furthermore, the effect of the severity of dementia was analyzed with a cut-off MMSE score of 19/20. Risk factors for surgical outcomes were explored using multivariate logistic regression analysis. Hospital mortality was 11.8% in the dementia group and 2.1% in the non-dementia group (P=0.002). Regarding the postoperative morbidities, the incidence of cerebrovascular disorder (P=0.001), pneumonia (P=0.039), delirium (P=0.004), and infection (P=0.006) was more frequent in dementia group. Among the patients with MMSE <20, hospital mortality was as high as 25%, and the rate of delirium was 58%. Multivariate logistic regression analysis revealed that MMSE score <24 (P=0.003), lower serum albumin (P=0.023) and aortic surgery (P=0.036) were independent risk factors for hospital death. CONCLUSIONS: Preoperative dementia affects the outcomes of cardiovascular surgery with regard to hospital death and delirium. The surgical indication for patients with MMSE <20 might be difficult, but surgery with an appropriate strategy should be considered for patients with MMSE <24.
Subject(s)
Cardiovascular Surgical Procedures/adverse effects , Dementia , Hospital Mortality , Mental Status and Dementia Tests , Postoperative Complications/mortality , Aged , Aged, 80 and over , Cerebrovascular Disorders/etiology , Cerebrovascular Disorders/mortality , Delirium/etiology , Delirium/mortality , Dementia/mortality , Dementia/surgery , Female , Humans , Incidence , Infections/etiology , Infections/mortality , Male , Pneumonia/etiology , Pneumonia/mortality , Risk Factors , Severity of Illness IndexSubject(s)
Chorea/diagnosis , Dementia/diagnosis , Dystonia/diagnosis , Hydrocephalus, Normal Pressure/diagnosis , Hydrocephalus, Normal Pressure/surgery , Ventriculoperitoneal Shunt , Aged , Brain/diagnostic imaging , Chorea/drug therapy , Chorea/etiology , Chorea/surgery , Dementia/drug therapy , Dementia/etiology , Dementia/surgery , Diagnosis, Differential , Dystonia/drug therapy , Dystonia/etiology , Dystonia/surgery , Female , Humans , Hydrocephalus, Normal Pressure/complications , Hydrocephalus, Normal Pressure/drug therapyABSTRACT
OBJECTIVE: Truncal vagotomy is associated with a decreased risk of subsequent Parkinson disease (PD), although the effect of vagotomy on dementia is unclear. In response, we investigated the risk of dementia in patients who underwent vagotomy. SETTING: Population-based cohort study. PARTICIPANTS: A total of 155 944 patients who underwent vagotomy (vagotomy cohort) and 155 944 age-matched, sex-matched and comorbidity-matched controls (non-vagotomy cohort) were identified between 2000 and 2011. PRIMARY AND SECONDARY OUTCOME MEASURES: All patient data were tracked until the diagnosis of dementia, death or the end of 2011. The cumulative incidence of subsequent dementia and HRs were calculated. RESULTS: The mean ages of the study patients in the vagotomy and non-vagotomy cohorts were 56.6±17.4 and 56.7±17.3 years, respectively. The overall incidence density rate for dementia was similar in the vagotomy and non-vagotomy cohorts (2.43 and 2.84 per 1000 person-years, respectively). After adjustment for age, sex and comorbidities such as diabetes, hypertension, hyperlipidaemia, stroke, depression, coronary artery disease and PD, the patients in the vagotomy cohort were determined to not be at a higher risk of dementia than those in the non-vagotomy cohort (adjusted HR=1.09, 95% CI 0.87 to 1.36). Moreover, the patients who underwent truncal vagotomy were not associated with risk of dementia (adjusted HR=1.04, 95% CI 0.87 to 1.25), compared with the patients who did not undergo vagotomy. CONCLUSION: Vagotomy, either truncal or selective, is not associated with risk of dementia.
Subject(s)
Dementia , Vagotomy , Adult , Aged , Cohort Studies , Comorbidity , Dementia/surgery , Female , Humans , Incidence , Male , Middle Aged , Proportional Hazards Models , Retrospective Studies , Risk Factors , TaiwanABSTRACT
Surgical intervention in older people with dementia is becoming increasingly common as the population ages and the number of people with dementia continues to rise. People with dementia have unique needs that require sensitive management at all stages of hospitalisation for surgery. This article sets out a suggested pathway for the care of these patients, in the form of a flow chart. It discusses recognition and assessment of dementia and delirium, issues of capacity and consent, interventions required for optimum care of older people with dementia and peri-operative management. It explores the role of family and friends in achieving integrated care.
Subject(s)
Dementia/surgery , Mentally Ill Persons , Nursing/methods , Postoperative Complications , Aged , Dementia/diagnosis , HumansSubject(s)
Dementia/surgery , Insulinoma/complications , Pancreatic Neoplasms/complications , Alzheimer Disease/diagnosis , Consciousness Disorders/etiology , Delayed Diagnosis , Dementia/diagnosis , Dementia/etiology , Diagnostic Errors , Diagnostic Imaging , False Negative Reactions , Female , Galantamine/therapeutic use , Humans , Hyperinsulinism/etiology , Hypoglycemia/etiology , Hypoglycemia/psychology , Insulinoma/diagnosis , Insulinoma/psychology , Insulinoma/surgery , Middle Aged , Nootropic Agents/therapeutic use , Pancreatectomy/methods , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/psychology , Pancreatic Neoplasms/surgery , Remission Induction , Weight GainABSTRACT
Introducción. La estimulación cerebral profunda (ECP) del núcleo subtalámico (NST) en la enfermedad de Parkinson (EP) es segura y eficaz: en la mayoría de series se describen respuestas motoras duraderas y estables. Objetivo. Informar sobre el desenlace a largo plazo de la ECP del NST en pacientes con EP avanzada atendidos en un centro hospitalario portugués. Pacientes y métodos. El estado motor se valoró con la escala unificada de valoración de la enfermedad de Parkinson, parte III, antes de la intervención quirúrgica -en dos situaciones: sin efecto de la medicación (off) y bajo el mejor efecto (on)-, en el postoperatorio y al cabo de cinco años (medicación y estimulación en on). Se cuantificaron las puntuaciones de cada síntoma axial. La incapacidad se evaluó con la escala de Rankin modificada (mRS). La aparición de demencia se valoró seis meses y cinco años después de la ECP. Resultados. Setenta y uno de los 183 pacientes sometidos a la ECP del NST concluyeron los cinco años de seguimiento. Diez de ellos quedaron excluidos: dos por fallecimiento (cáncer e infarto de miocardio), cinco por pérdida de seguimiento y tres por la retirada del sistema de estimulación. La función motora manifestó una mejora del 78% en el postoperatorio y del 66% a los cinco años. En el postoperatorio se apreció mejoría de los síntomas axiales, pero al cabo de los cinco años habían empeorado de manera significativa (p < 0,001). Las puntuaciones de la mRS también mejoraron en el postoperatorio, pero a los cinco años también habían disminuido, pese a que la mayoría (88,5%) conservaba la capacidad ambulatoria (mRS < 4). Un paciente (1,6%) manifestó demencia a los seis meses, mientras que otros 19 (31,2%) la manifestaron al cabo de los cinco años. La edad de los pacientes dementes era notablemente mayor (56,5 ± 7,8 frente a 63,7 ± 5,9 años; p < 0,001). Conclusiones. En esta serie de casos, la ECP del NST demostró su eficacia en la mejora de los síntomas motores, aunque habían transcurrido cinco años desde la implantación. En ese período hubo un deterioro de los síntomas axiales y de la incapacidad, y surgieron casos de demencia, pero el posible papel de la ECP del NST como factor causal resta pendiente de concretar (AU)
Introduction. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) in Parkinsons disease (PD) is safe and effective. Most series report stable long-term motor responses. Aim. To report the long-term outcome of STN-DBS in advanced stage PD patients at a Portuguese center. Patients and methods. Motor status was evaluated before surgery (off medication and best on), post-operatively, and at five years (on medication and stimulation) using UPDRS part III. Axial symptoms subscores were quantified. Disability was assessed with the modified Rankin Scale (mRS). Development of dementia was assessed at 6 months and five years post-DBS. Results. Of the 183 patients submitted to STN-DBS, 71 had completed 5 years of follow-up. Ten patients were not included: two died (cancer, myocardial infarction), five were lost to follow-up and three had their stimulation systems removed. Motor function improved by 78% and 66% postoperatively and at five years, respectively. There was improvement of axial symptoms postoperatively, with significant worsening at five years (p < 0.001). mRS scores improved postoperatively, but declined at five years, although most patients (88.5%) remained ambulatory (mRS < 4). One patient (1.6%) and 19 patients (31,2%) were demented at 6 months and 5 years, respectively. Patients who developed dementia were significantly older than non-demented patients (56.5 ± 7.8 vs 63.7 ± 5.9 years-old; p < 0.001). Conclusions. In this series STN-DBS proved its efficacy regarding motor symptom improvement even five years after the procedure. Deterioration of axial symptoms and disability, as well as new onset dementia were observed in this period, but the possible role of STN-DBS as a causative factor is yet to be defined (AU)
Subject(s)
Humans , Deep Brain Stimulation/methods , Subthalamic Nucleus , Parkinson Disease/surgery , Dementia/surgery , Motor Skills Disorders/rehabilitation , Cognition Disorders/rehabilitation , Stereotaxic Techniques , Magnetic Resonance SpectroscopyABSTRACT
Normal pressure hydrocephalus, a reversible cause of dementia, and frontotemporal dementia, an irreversible process, may present with or complicate psychiatric illness. Recognition of these neurological disorders in patients presenting with behavioral symptoms affects key treatment decisions and prognosis.
Subject(s)
Behavioral Symptoms/diagnosis , Cerebrospinal Fluid Shunts , Dementia/diagnosis , Hydrocephalus, Normal Pressure/diagnosis , Aged, 80 and over , Behavioral Symptoms/physiopathology , Dementia/etiology , Dementia/surgery , Diagnosis, Differential , Humans , Hydrocephalus, Normal Pressure/complications , Hydrocephalus, Normal Pressure/surgery , Male , Treatment OutcomeABSTRACT
OBJECT: For several decades, clinicians have predicted intraparenchymal brain pressure or brain tissue compression indirectly based on the degree of distortion of the midline structures (midline shift) and ventricle wall (ventriculomegaly) observed on conventional MRI. However, this method has several limitations. Diffusion tensor imaging (DTI) is a novel MRI technique that can provide information about the microstructural properties of compressed tissue. In this study, the authors evaluated whether DTI can precisely define the degree of tissue compression in patients with chronic subdural hematoma (CSDH). METHODS: The study sample consisted of 18 patients (mean age 71 years, 10 men and 8 women) with unilateral CSDH and 12 age-matched volunteers. Diffusion tensor imaging results were acquired before and after the surgical irrigation in the CSDH group. Subdural pressure during the operation was also measured. Fractional anisotropy (FA) values were evaluated at several locations, including the gray matter. RESULTS: The FA values of the gray matter, especially in the caudate nucleus and putamen, were increased in the patients with CSDH compared with the control group. The change in FA data before and after surgery (ΔFA) correlated with the degree of tissue compression evaluated by measurement of the subdural pressure. Furthermore, the increased FA values in patients with CSDH decreased after surgery. CONCLUSIONS: These findings indicate that FA values of the gray matter, especially in the caudate nucleus and putamen, may be important markers of tissue compression. The assessment of FA values of the gray matter will result in a new, less-invasive diagnostic technique to evaluate the degree of brain compression.
Subject(s)
Brain/physiopathology , Diffusion Magnetic Resonance Imaging/methods , Hematoma, Subdural, Chronic/physiopathology , Image Enhancement/methods , Image Interpretation, Computer-Assisted/methods , Intracranial Pressure/physiology , Aged , Aged, 80 and over , Anisotropy , Brain/surgery , Caudate Nucleus/physiopathology , Caudate Nucleus/surgery , Dementia/physiopathology , Dementia/surgery , Dominance, Cerebral/physiology , Female , Gait Disorders, Neurologic/physiopathology , Gait Disorders, Neurologic/surgery , Hematoma, Subdural, Chronic/surgery , Humans , Male , Middle Aged , Paresis/physiopathology , Paresis/surgery , Postoperative Complications/physiopathology , Prospective Studies , Putamen/physiopathology , Putamen/surgery , TrephiningABSTRACT
Spiroplasma spp. are important phyto and insect pathogens, and candidate causal agent/s of transmissible spongiform encephalopathies (TSE) in man and animals. These filterable wall-less bacteria are widely distributed in nature with an unspecified environmental reservoir. In this study we showed by scanning electron microscopy that spiroplasma form biofilm on an assortment of hard surfaces including mica, nickel and stainless steel. Spiroplasma were stuck to the surfaces by fibrillar threads consistent with curli fibers (an amyloid protein found in bacterial biofilms). After a lengthy time in cultures (6 weeks), spiroplasma in biofilm bound to mica disks lost their spiral shapes and formed coccoid forms interconnected by long (>2 µm) branched membranous nanotubules, therein representing direct conjugate connections between the cells. The affinity of spiroplasma biofilms for mica and nickel, and the membrane communications suggest that soil could be a reservoir for these bacteria. The persistence of clay bound spiroplasma in soil could serve as the mechanism of lateral spread of TSEs by ingestion of soil by ruminants. Spiroplasma binding to stainless steel wire supports bacterial contamination of surgical instruments following surgery on dementia patients as a mechanism of iatrogenic transmission of TSEs, especially with resistance of spiroplasma in biofilms to drying or exposure to 50% glutaraldehyde. The discovery of biofilm formation by spiroplasma addresses questions regarding environmental persistence of these organisms in nature and suggests novel mechanisms of intercellular communication and transmission.
Subject(s)
Biofilms , Spiroplasma/physiology , Animals , Dementia/surgery , Humans , Insecta/microbiology , Plant Diseases/microbiology , Prion Diseases/microbiology , Prion Diseases/transmission , Ruminants/microbiology , Soil Microbiology , Spiroplasma/ultrastructure , Stainless Steel , Surgical Instruments/microbiologyABSTRACT
There are currently 25 million people with dementia worldwide, and this number is rising. Dementia has been highlighted as a major priority for health care and research because of the enormous economical and health burden associated with it. Consultations with people with dementia and carers have highlighted that timely well-targeted information services are a key priority for enabling them to 'live well with dementia'. Despite this, the evidence base for the optimal design and delivery of an information provision service is limited. Findings from randomised controlled trials and other studies have indicated that information provision does confer some benefit in carer outcomes and in the symptoms and well-being of people with dementia. However, there is limited understanding of the optimal design of such a service because of the variety of approaches that have been evaluated, the wide range of settings and locations and the lack of a clear conceptual framework. The existing evidence base supports the importance of an optimised information provision service and strongly indicates the need for a large-scale RCT to identify the most effective and cost-effective design for people with dementia and their carers.